GILEAD SCIENCES, INC. Operating Cash Flow 2007-2026 | GILD
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is GILEAD SCIENCES, INC.'s current operating cash flow?
GILEAD SCIENCES, INC. (GILD) annual operating cash flow for 2025 was $10.02B, a 7.47% decline from 2024. GILEAD SCIENCES, INC. operating cash flow for the quarter ending March 31, 2026 was $2.54B.
What was GILEAD SCIENCES, INC.'s operating cash flow in 2024?
GILEAD SCIENCES, INC. annual operating cash flow for 2024 was $10.83B, a 35.25% increase from 2023.
What was GILEAD SCIENCES, INC.'s operating cash flow in 2023?
GILEAD SCIENCES, INC. annual operating cash flow for 2023 was $8.01B, a 11.75% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year operating cash flow CAGR?
GILEAD SCIENCES, INC. operating cash flow grew at a compound annual growth rate (CAGR) of 4.17% from FY2020 to FY2025, going from $8.17B to $10.02B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $10.02B | -7.5% | 10-K |
| FY2024 | $10.83B | +35.2% | 10-K |
| FY2023 | $8.01B | -11.8% | 10-K |
| FY2022 | $9.07B | -20.3% | 10-K |
| FY2021 | $11.38B | +39.4% | 10-K |
| FY2020 | $8.17B | -10.7% | 10-K |
| FY2019 | $9.14B | +8.9% | 10-K |
| FY2018 | $8.40B | -29.4% | 10-K |
| FY2017 | $11.90B | -30.2% | 10-K |
| FY2016 | $17.05B | -19.8% | 10-K |
| FY2015 | $21.25B | +65.8% | 10-K |
| FY2014 | $12.82B | +312.8% | 10-K |
| FY2013 | $3.10B | -2.8% | 10-K |
| FY2012 | $3.19B | -12.2% | 10-K |
| FY2011 | $3.64B | +28.4% | 10-K |
| FY2010 | $2.83B | -8.0% | 10-K |
| FY2009 | $3.08B | +43.7% | 10-K |
| FY2008 | $2.14B | +28.4% | 10-K |
| FY2007 | $1.67B | - | 10-K |